Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

被引:41
|
作者
Dilley, James [1 ]
Burnell, Matthew [1 ]
Gentry-Maharaj, Aleksandra [1 ]
Ryan, Andy [1 ]
Neophytou, Christina [1 ]
Apostolidou, Sophia [1 ]
Karpinskyj, Chloe [1 ]
Kalsi, Jatinderpal [11 ]
Mould, Tim [2 ]
Woolas, Robert [3 ]
Singh, Naveena [4 ]
Widschwendter, Martin [11 ]
Fallowfield, Lesley [5 ]
Campbell, Stuart [6 ]
Skates, Steven J. [7 ,8 ]
McGuire, Alistair [9 ]
Parmar, Mahesh [1 ]
Jacobs, Ian [10 ]
Menon, Usha [1 ]
机构
[1] UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit UCL, 2nd Floor, London WC1V 6LJ, England
[2] Univ Coll London Hosp, London, England
[3] Queen Alexandra Hosp, Portsmouth, Hants, England
[4] Barts Hlth NHS Trust, London, England
[5] Univ Sussex, Brighton & Sussex Med Sch, Sussex Hlth Outcomes Res & Educ Canc SHORE C, Brighton, E Sussex, England
[6] Create Hlth London, London, England
[7] Massachusetts Gen Hosp, Boston, MA 02114 USA
[8] Harvard Med Sch, Boston, MA 02115 USA
[9] London Sch Econ, London, England
[10] Univ New South Wales, Sydney, NSW, Australia
[11] UCL, Inst Womens Hlth, London, England
基金
英国医学研究理事会;
关键词
Ovarian cancer; Symptoms; Routes to diagnosis; Survival; UKCTOCS; GOFF index; NICE; PREDICTIVE-VALUE; WOMEN; OUTCOMES; TIME; DELAY; STAGE;
D O I
10.1016/j.ygyno.2020.05.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. There are widespread efforts to increase symptom awareness of 'pelvic/abdominal pain, increased abdominal size/bloating, difficulty eating/feeling full and urinary frequency/urgency' in an attempt to diagnose ovarian cancer earlier. Long-term survival of women with these symptoms adjusted for known prognostic factors is yet to be determined. This study explored the association of symptoms, routes and interval to diagnosis and long-term survival in a population-based cohort of postmenopausal women diagnosed with invasive epithelial tubo-ovarian cancer (iE0C) in the 'no screen' (control) UKCTOCS arm. Methods. Of 101,299 women in the control arm. 574 were confirmed on outcome review to have iE0C between randomisation (2001-2005) and 31 December 2014. Data was extracted from medical notes and electronic records. A multivariable model was fitted for individual symptoms, time interval from symptom onset to diagnosis, route to diagnosis, speciality, morphological Type, age at diagnosis, year of diagnosis (period effect), stage, primary treatment, and residual disease. Results. Women presenting with symptoms listed in the NICE guidelines (HR1.48, 95%CI 1.16-1.89, p = 0.001) or the modified Goff Index (HR1- 68, 95%CI 1.32-2.13, p < 0.0001) had significantly worse survival than those who did not. Each additional presenting symptom decreased survival (HR1.20, 95%CI 1.12-1.28, p < 0.0001). In multivariable analysis, in addition to advanced stage, increasing residual disease and inadequate primary treatment, abdominal pain and loss of appetite/feeling full were significantly associated with increased mortality. Conclusions. The ovarian cancer symptom indices identify postmenopausal women with a poorer prognosis. This study however cannot exclude the possibility of better outcomes in those who are aware and act on their symptoms. (C) 2020 The Authors. Published by Elsevier Inc.
引用
收藏
页码:316 / 322
页数:7
相关论文
共 50 条
  • [1] Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
    Dilley, James
    Gentry-Maharaj, Aleksandra
    Ryan, Andy
    Burnell, Matthew
    Manchanda, Ranjit
    Kalsi, Jatinderpal
    Singh, Naveena
    Woolas, Robert
    Sharma, Aarti
    Williamson, Karin
    Mould, Tim
    Fallowfield, Lesley
    Campbell, Stuart
    Skates, Steven J.
    McGuire, Alistair
    Parmar, Mahesh
    Jacobs, Ian
    Menon, Usha
    GYNECOLOGIC ONCOLOGY, 2023, 179 : 123 - 130
  • [2] The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
    Usha Menon
    Alistair J McGuire
    Maria Raikou
    Andy Ryan
    Susan K Davies
    Matthew Burnell
    Aleksandra Gentry-Maharaj
    Jatinderpal K Kalsi
    Naveena Singh
    Nazar N Amso
    Derek Cruickshank
    Stephen Dobbs
    Keith Godfrey
    Jonathan Herod
    Simon Leeson
    Tim Mould
    John Murdoch
    David Oram
    Ian Scott
    Mourad W Seif
    Karin Williamson
    Robert Woolas
    Lesley Fallowfield
    Stuart Campbell
    Steven J Skates
    Mahesh Parmar
    Ian J Jacobs
    British Journal of Cancer, 2017, 117 : 619 - 627
  • [3] The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
    Menon, Usha
    McGuire, Alistair J.
    Raikou, Maria
    Ryan, Andy
    Davies, Susan K.
    Burnell, Matthew
    Gentry-Maharaj, Aleksandra
    Kalsi, Jatinderpal K.
    Singh, Naveena
    Amso, Nazar N.
    Cruickshank, Derek
    Dobbs, Stephen
    Godfrey, Keith
    Herod, Jonathan
    Leeson, Simon
    Mould, Tim
    Murdoch, John
    Oram, David
    Scott, Ian
    Seif, Mourad W.
    Williamson, Karin
    Woolas, Robert
    Fallowfield, Lesley
    Campbell, Stuart
    Skates, Steven J.
    Parmar, Mahesh
    Jacobs, Ian J.
    BRITISH JOURNAL OF CANCER, 2017, 117 (05) : 619 - 627
  • [4] Assessing the malignant potential of ovarian inclusion cysts in postmenopausal women within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a prospective cohort study
    Sharma, A.
    Gentry-Maharaj, A.
    Burnell, M.
    Fourkala, E-O
    Campbell, S.
    Amso, N.
    Seif, M. W.
    Ryan, A.
    Parmar, M.
    Jacobs, I.
    Menon, U.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (02) : 207 - 219
  • [5] Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS)
    Sharma, A.
    Apostolidou, S.
    Burnell, M.
    Campbell, S.
    Habib, M.
    Gentry-Maharaj, A.
    Amso, N.
    Seif, M. W.
    Fletcher, G.
    Singh, N.
    Benjamin, E.
    Brunell, C.
    Turner, G.
    Rangar, R.
    Godfrey, K.
    Oram, D.
    Herod, J.
    Williamson, K.
    Jenkins, H.
    Mould, T.
    Woolas, R.
    Murdoch, J.
    Dobbs, S.
    Leeson, S.
    Cruickshank, D.
    Fourkala, E. -O.
    Ryan, A.
    Parmar, M.
    Jacobs, I.
    Menon, U.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2012, 40 (03) : 338 - 344
  • [6] Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
    Menon, Usha
    Gentry-Maharaj, Aleksandra
    Hallett, Rachel
    Ryan, Andy
    Burnell, Matthew
    Sharma, Aarti
    Lewis, Sara
    Davies, Susan
    Philpott, Susan
    Lopes, Alberto
    Godfrey, Keith
    Oram, David
    Herod, Jonathan
    Williamson, Karin
    Seif, Mourad W.
    Scott, Ian
    Mould, Tim
    Woolas, Robert
    Murdoch, John
    Dobbs, Stephen
    Amso, Nazar N.
    Leeson, Simon
    Cruickshank, Derek
    Mcguire, Alistair
    Campbell, Stuart
    Fallowfield, Lesley
    Singh, Naveena
    Dawnay, Anne
    Skates, Steven
    Parmar, Mahesh
    Jacobs, Ian
    LANCET ONCOLOGY, 2009, 10 (04) : 327 - 340
  • [7] Performance Characteristics of the Ultrasound Strategy during Incidence Screening in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
    Kalsi, Jatinderpal
    Gentry-Maharaj, Aleksandra
    Ryan, Andy
    Singh, Naveena
    Burnell, Matthew
    Massingham, Susan
    Apostolidou, Sophia
    Sharma, Aarti
    Williamson, Karin
    Seif, Mourad
    Mould, Tim
    Woolas, Robert
    Dobbs, Stephen
    Leeson, Simon
    Fallowfield, Lesley
    Skates, Steven J.
    Parmar, Mahesh
    Campbell, Stuart
    Jacobs, Ian
    McGuire, Alistair
    Menon, Usha
    CANCERS, 2021, 13 (04) : 1 - 13
  • [8] Validity of self-reported hysterectomy: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
    Gentry-Maharaj, Aleksandra
    Taylor, Henry
    Kalsi, Jatinderpal
    Ryan, Andy
    Burnell, Matthew
    Sharma, Aarti
    Apostolidou, Sophia
    Campbell, Stuart
    Jacobs, Ian
    Menon, Usha
    BMJ OPEN, 2014, 4 (03):
  • [9] Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
    Menon, Usha
    Gentry-Maharaj, Aleksandra
    Burnell, Matthew
    Singh, Naveena
    Ryan, Andy
    Karpinskyj, Chloe
    Carlino, Giulia
    Taylor, Julie
    Massingham, Susan K.
    Raikou, Maria
    Kalsi, Jatinderpal K.
    Woolas, Robert
    Manchanda, Ranjit
    Arora, Rupali
    Casey, Laura
    Dawnay, Anne
    Dobbs, Stephen
    Leeson, Simon
    Mould, Tim
    Seif, Mourad W.
    Sharma, Aarti
    Williamson, Karin
    Liu, Yiling
    Fallowfield, Lesley
    McGuire, Alistair J.
    Campbell, Stuart
    Skates, Steven J.
    Jacobs, Ian J.
    Parmar, Mahesh
    LANCET, 2021, 397 (10290) : 2182 - 2193
  • [10] Pathways to diagnosis of endometrial and ovarian cancer in the 45 and Up Study cohort
    Yap, Sarsha
    Vassallo, Amy
    Goldsbury, David
    O'Connell, Dianne L.
    Brand, Alison
    Emery, Jon
    DeFazio, Anna
    Canfell, Karen
    Steinberg, Julia
    CANCER CAUSES & CONTROL, 2023, 34 (01) : 47 - 58